-The Times of India chennai: One of the three convicts on death row for the assassination of Rajiv Gandhi, AG Perarivalan, will on Monday be on a videoconference with Central Information Commissioner Satyananda Mishra on a complaint against Rashtrapati Bhavan and the ministry of home affairs on a petition seeking to know why his mercy plea was rejected in August 2011. A notification on the videoconference was fixed three days ago...
More »SEARCH RESULT
Total Matching Records found : 1128
Retaining the aroma-Sushanta Talukdar
-The Hindu Efforts are on to obtain Geographical Indication tag for the fragrant non-Basmati joha rice varieties of Assam As the aroma of Assam's joha rice varieties that make the fragrant pulao, delicious Assamese dessert payash and are a must for a number of ethnic delicacies spread far and wide, the State government has begun the technical exercise to obtain Geographical Indication (GI) tag for joha rice to protect these indigenous varieties...
More »3 IITs among top 100 universities in Asia -M Ramya
-The Times of India chennai: Only three institutes in the country, all of them Indian Institutes of Technology, feature among the top 100 universities in Asia, according to the first Asia University Rankings released by "Times Higher Education" magazine. While IIT-Kharagpur is ranked 30th, IIT-Bombay is 33rd and IIT-Roorkee 56th, the University of Tokyo secured the pole position with an overall score of 78.3, followed by the National University of Singapore...
More »Pickles, papads, junk food raise risk of hypertension: Experts -Malathy Iyer
-The Times of India MUMBAI: The urban Indian's diet, pickled with takeaways from fast-food joints and instant foods that are ready in a jiffy at the end of a long working day, could worsen the present epidemic of hypertension due to its high proportion of salt. In a city where every fourth adult is believed to have hypertension, experts said the focus should be on reducing salt intake in the daily...
More »Finally, the patients prevail -Sarah Hiddleston
-The Hindu The Supreme Court has denied Novartis a patent for its anti-cancer drug Gleevec. This leaves the door open for Indian pharmaceutical companies to produce their own versions of the drug. Since these are sold at roughly one tenth of the patented brand price, for thousands of cancer patients it means the difference between medicine and no medicine at all. It is not just cancer patients that will benefit, but...
More »
